By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
LONG-TERM ARCHIVING OF BENTHAM SCIENCE CONTENT
To ensure permanent access to our publications, Bentham Science has an agreement with Portico to have a long-term preservation of the content published in its journals.
Arduino A. Mangoni Flinders University and Flinders Medical Centre Adelaide, SA (Australia)
Professor Arduino A Mangoni trained in Cardiology, Clinical Pharmacology and General Medicine in Milan, Boston and London. He was awarded a PhD in Pharmacology at King’s College, University of London, in 2003. He was appointed Senior Lecturer (2003-2007) and Associate Professor (2007-2009) in Clinical Pharmacology at Flinders University before taking up the Chair in Medicine of Old Age at the University of Aberdeen, UK (2010-2012). In 2013 he was appointed Strategic Professor of Clinical Pharmacology and Head of Department at Flinders University. In 2015, he became Associate Dean and Head, Flinders Medical Science and Technology. He plays a key role in the regular review of the Australian Hypertension guidelines and has contributed to the development of the SIGN guidelines on the Management of Chronic Pain, released in December 2013. His research interest include metabolomics and ageing, drug discovery and geriatric clinical pharmacology. Professor Mangoni has published over 140 refereed publications. Arduino Mangoni is a clinical academic, Professor and Head of the Department of Clinical Pharmacology and Associate Dean and Head, Flinders Medical Science and Technology, in the School of Medicine at Flinders University in Adelaide.